Metadichol-Induced KLF Expression in PBMC Cells. Links SIRTs, NRs, TLRs, and Circadian genes. A Systems-Wide Biology Approach

Metadichol expresses all nuclear receptors, the TLR family (1-10), the Sirtuin family (1-7), all 48 nuclear receptors, and all Yamanaka factors: Oct 4, Sox2, KLF4, C-myc, and circadian genes: Per1, CRY1, BMAL1, CLOCK, and PPARGC1A. The transcription factor family Kruppel-like factors (KLFs) is essential for cell proliferation, differentiation, and development. Our tiny chemical, Metadichol, a long-chain lipid alcohol nanoemulsion, modulates KLF family 1-18 expression. Concentration dependent. At 1 ng/ml, 16 of 18 KLF transcription factors are downregulated, save KLF 4 and 18. Small chemical modulators of KLF expression and activity offer new therapeutic approaches for many disorders, including cancer. In immunotherapy, KLF10 inhibition may reduce T regulatory cell numbers or function to boost anti-tumor immunity. Small compounds substituting KLF4 in cellular reprogramming could increase iPSC production efficiency and safety in regenerative medicine. In addition to KLF family expression results, this research will examine the regulation mechanisms of KLFs, nuclear receptors, SIRTs, circadian genes, Toll-like receptors, Klotho, P53, and PPARGC1A in cancer. These protein families form a dynamic web of interconnected signaling networks that affect cancer biology, including the mechanisms of crosstalk between them, the roles of individual members in different cancer types, and the tumor microenvironment's effect on these interactions. Our research reveals that molecular biology, genetics, immunology, and clinical oncology must be integrated to understand cancer's intricate networks. This will allow novel therapeutic techniques to target gene family connections, improving cancer therapy results and tumor biology understanding.